American Biomanufacturing Summit
Lunch & Learn
Roundtables
1:00 pm – 2:00 pm
Table 1
Rahul Kaushik
Chief Technical Officer
Disc Medicine
What, how, when: navigating CMC considerations for programs on an accelerated approval pathway
Spots Remaining: 0
TABLE 2
Andy Lin
VP and Global Head, Individualized and Cell Therapy Development, Pharma Technical
Genentech
Enhancing the Development and Manufacturing of Individualized Cell Therapies
Spots Remaining: 0
TABLE 3
Andrew Wirths
SVP, Global Operations
AstraZeneca
Achieving Carbon Zero: AstraZeneca's Path to Sustainability in Manufacturing
Spots Remaining: 0
TABLE 4
Christopher Grail
SVP and Head, Global Pharma Engineering
Bayer
Danielle Golay
VP, Biologics and Cell Therapy Quality
Bayer
Synergistic Collaboration Between Production, Engineering and Quality as Important Success Factors In Manufacturing
Spots Remaining: 0
TABLE 5
Suki Toguchi
Chief of Staff
Gilead Sciences
Leading Digital Strategy: Driving Transformation Across Gilead’s Pharma Development and Manufacturing
Spots Remaining: 0
TABLE 6
Rakesh Kakkar
VP and Head, Manufacturing and Supply Vaccines, US
Sanofi
Driving Operational excellence, Quality and Compliance in Biomanufacturing
Spots Remaining: 0